| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |